0001213900-22-001613.txt : 20220111
0001213900-22-001613.hdr.sgml : 20220111
20220111203027
ACCESSION NUMBER: 0001213900-22-001613
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220111
DATE AS OF CHANGE: 20220111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIDRON NADAV
CENTRAL INDEX KEY: 0001351779
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35813
FILM NUMBER: 22525254
MAIL ADDRESS:
STREET 1: 142 W. 57TH ST.
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001176309
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980376008
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0831
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-844-1164
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Integrated Security Technologies, Inc.
DATE OF NAME CHANGE: 20040614
FORMER COMPANY:
FORMER CONFORMED NAME: IGUANA VENTURES LTD
DATE OF NAME CHANGE: 20020625
4/A
1
ownership.xml
X0306
4/A
2022-01-03
2022-01-05
0
0001176309
ORAMED PHARMACEUTICALS INC.
ORMP
0001351779
KIDRON NADAV
1185 AVENUE OF THE AMERICAS,
THIRD FLOOR
NEW YORK,
NY
10036
1
1
0
0
President and CEO
Common Stock
2022-01-03
4
A
0
150000
A
916481
D
Common Stock
2022-01-03
4
F
0
48752
13.89
D
867729
D
Common Stock
2022-01-03
4
A
0
63000
A
930729
D
Stock Option (right to buy
13.89
2022-01-03
4
A
0
107000
0
A
2032-01-03
Common Stock
107000
107000
D
Represents Common Stock granted by the Issuer that vested upon grant.
Payment of tax liability by withholding securities incident to the 150,000 shares of Common Stock granted on January 3, 2022.
Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 15,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Kidron, which reported that 950,729 shares of common stock are beneficially owned by him following the reported transactions. Mr. Kidron beneficially owned 930,729 shares of common stock following the reported transactions.
The Stock Option will vest in 4 installments as follows: 26,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.
/s/ Nadav Kidron
2022-01-11